'Oilseeds Kisaan Mitra' - India's First Nationwide WhatsApp AI Advisory for Oilseed Farmers (See 'Corp Brief') IPC strengthens Industry Preparedness for IP 2026 (See 'Corp Brief') IBC - If application for withdrawal of CIRP u/s 12A is supported by duly submitted Form FA, accompanied by required bank guarantee, and placed before CoC within prescribed time, AA may permit withdrawal of CIRP: NCLT (See 'Legal Desk') Vaishnaw inaugurates 20 kW Akashvani FM Transmitter at Ramgarh, Jaisalmer (See 'Corp Brief') Goyal to visit Switzerland to promote India-EFTA trade deal (See 'Corp Brief') MoS calls upon Industry to scale up Investments in India's Space Sector (See 'Corp Brief') IBC - Incorrect disclosure in Form B does not by itself extinguish statutory charge, particularly where RP otherwise had notice of lien and statutory basis claimed by tax authority: NCLAT (See 'Legal Desk') SAPLING Dialogue 2026 Concludes with Call for holistic development of food processing Sector (See 'Corp Brief') Measures activated to shield Domestic Fertilizer Supply from Global Geo-Political Disruptions: Govt (See 'Corp Brief') CCI approves acquisition of certain shareholding in PUMA SE by Ancat Holding (See 'Corp Brief') IBC - Write-off of inventory may be held fraudulent u/s 66(1) if surrounding facts show non-maintenance and withholding of stock records, inconsistency between inventory figures and operational trends: NCLT (See 'Legal Desk') CCI approves acquisition of equity in Shriram Life Insurance by Sanlam Emerging Markets (See 'Corp Brief') Ministry of Coal to organize Roadshow on Coal and Lignite Gasification Projects in Hyderabad (See 'Corp Brief') MoS leads delegation at 114th International Labour Conference in Geneva (See 'Corp Brief') No ban on Import of Indian Mangoes by Nepal (See 'Corp Brief') IBC - Advance paid to corporate debtor for supply of goods or services, where claim has nexus with provision of goods or services, constitutes operational debt within meaning of Sec 5(21): NCLT (See 'Legal Desk') TRAI issues amended 'Rating Manual 2026' for assessment of Digital Connectivity (See 'Corp Brief') Zojila Tunnel to establish All-Weather Connectivity Between J&K and Ladakh (See 'Corp Brief') IPR - Foreign FRAND rate-setting action filed by implementer may be treated as relevant material at pro tem stage in assessing prima facie essentiality / need for licensing: HC (See 'Legal Desk') Ministry of MSME Promoting Inclusive Entrepreneurship through National SC-ST Hub Scheme (See 'Corp Brief') GeM Boosts MSE Inclusion: Registered Units Rise to 11.9 Lakh (See 'Corp Brief') Strong, transparent and modern cooperative institutions will energise rural economy: Bhutani (See 'Corp Brief') Trade Marks - CALPOL & CALPOL FAST medicines granted status of well-known trademark as material demonstrates strong consumer association of mark with Plaintiff & its distinctiveness in pharma sector: HC (See 'Legal Desk') SAIL sharpens strategic priorities for FY27, reinforces market position (See 'Corp Brief') Railways sanctions upgradation of Electric Traction System on Bengaluru-Tumkur Section (See 'Corp Brief') IBC - Once resolution plan was approved by CoC, successful resolution applicant is bound by it and cannot seek to evade implementation by raising objections to LoI stipulations that are inherent in process: SC (See 'Legal Desk') Railways sanctions upgradation of Electric Traction System on Mahbubnagar-Secunderabad Section (See 'Corp Brief') Capital Market - Finding of 'fraud' under SEBI PFUTP Regulations, 2003, cannot be sustained, if Securities Appellate Tribunal had committed 'egregious error' in affirming SEBI's conclusions on manipulation & fraudulent intent: SC (See 'Legal Desk') MoS inaugurates Self-ticketing Kiosks at National Zoological Park (See 'Corp Brief') Ministry of Panchayati Raj to organise outreach workshop on Atmanirbhar Panchayat Program (See 'Corp Brief') Mandaviya leads nationwide World Bicycle Day celebrations with actor Vikrant Massey (See 'Corp Brief') IPR - Nature of enquiry u/s 57, being one for cancellation or rectification of register, is founded upon appreciation of statutory parameters such as distinctiveness, prior use and likelihood of confusion: HC (See 'Legal Desk') MoS inaugurates Daycare Facility for Children of MSDE Employees at Kaushal Bhawan (See 'Corp Brief') National Biodiversity Authority Celebrates World Environment Day 2026 (See 'Corp Brief') AI-enabled Sayuj App & Open Challenge Program 1.0 launched to strengthen Startup Ecosystem: MoS (See 'Corp Brief') Over 6,000 youth from across country to celebrate innovation & leadership (See 'Corp Brief') IBC - Land leased by statutory authority cannot be excluded from Corporate Debtor's assets on ground that development rights were transferred without consent: NCLT (See 'Legal Desk') IBC's Primacy Over the Electricity Act and the Extinguishment of Pre-CIRP Claims (See CORP EINSICHT)

Print

IPC strengthens Industry Preparedness for IP 2026

Published: Jun 12, 2026

By TIOLCorplaws News Service

NEW DELHI, JUN 12, 2026: THE Indian Pharmacopoeia Commission (IPC), an autonomous institution under the Ministry of Health and Family Welfare, Government of India, organized a Scientific Conclave and Interactive Session on Indian Pharmacopoeia (IP) 2026 "Strengthening Pharmaceutical Manufacturing through Pharmacopoeial Standards and Quality Compliance" at Haridwar yesterday, in collaboration with the Association of Devbhumi Pharma Industries (ADPI) and affiliated pharmaceutical manufacturing associations of Uttarakhand. The conclave was organized with the objective of enhancing awareness on the provisions of IP 2026 and promoting quality compliance across the pharmaceutical manufacturing sector.

Uttarakhand is one of India's leading pharmaceutical manufacturing hubs and has been among the states effectively utilizing the IP and Indian Pharmacopoeia Reference Substances for ensuring the quality, safety, and efficacy of medicines. Recognizing the state's significant contribution to pharmaceutical manufacturing, the conclave was organized to further strengthen industry awareness, support compliance with pharmacopoeial requirements, and promote the consistent adoption of IP standards across the pharmaceutical sector, thereby providing handholding support to pharmaceutical manufacturers and other stakeholders in the state.

The programme brought together representatives from pharmaceutical manufacturing units, quality control and quality assurance professionals, regulatory authorities, analytical scientists, and drug testing laboratory personnel to deliberate on recent developments in pharmacopoeial standards and their implementation in the pharmaceutical industry.

The inaugural session commenced with a welcome address by Sandeep Jain, Chairman, ADPI. Addressing the gathering, he emphasized the importance of collaboration between industry and standard-setting bodies in strengthening pharmaceutical quality systems.

The session was also addressed by Sidharth Sahai Malhotra, Assistant Drugs Controller (India), CDSCO, Dehradun, and Tajber Singh, Drug Controller and State Licensing Authority, Uttarakhand, who highlighted the critical role of pharmacopoeial standards in ensuring regulatory compliance and safeguarding public health.

Delivering the Chief Guest address, Dr. V. Kalaiselvan, Secretary-cum-Scientific Director, IPC, underscored the pivotal role of the IP in establishing scientifically validated quality standards for medicines and supporting India's growing stature as a global pharmaceutical leader. He highlighted the key advancements incorporated in IP 2026 and emphasized the importance of industry participation in ensuring the effective implementation of pharmacopoeial requirements.

Following the inaugural session, a series of technical deliberations and knowledge-sharing interactions were conducted on key aspects of the IP, including recent developments in pharmacopoeial standards, reference substances, microbiological quality requirements, quality management systems, analytical investigations and biological standards. The sessions provided participants with practical insights into the application of IP standards in pharmaceutical manufacturing and quality control.

A dedicated interactive session provided participants with an opportunity to engage directly with IPC scientists and seek clarifications on technical, regulatory and implementation-related aspects of IP 2026. The discussions reflected the industry's keen interest in understanding evolving pharmacopoeial requirements and adopting best practices for quality assurance.

The conclave reaffirmed IPC's commitment to fostering greater awareness of pharmacopoeial standards and strengthening collaboration with stakeholders to promote the manufacture of quality-assured medicines. The event concluded with a networking session, enabling continued dialogue among regulators, industry representatives, and scientific experts on advancing pharmaceutical quality and compliance in Uttarakhand and across the country.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.